New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects
Mineralocorticoid receptor antagonists have been successfully used for many years to treat patients with primary hyperaldosteronism, refractory arterial hypertension and chronic heart failure. The increased interest in this drug in recent years is due to new information about its antifibrotic and an...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | RU |
| Publié: |
"Consilium Medicum" Publishing house
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e182cb868ad24da2ad9e2ac5a9fda2c2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!